L

    Lantheus Holdings Inc (LNTH)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $100.96
    +0.19 (+0.19%)

    Market Cap: $6.58B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    90%(36/40)
    Avg Surprise
    +61.82%
    Streak
    4 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$1.35
    Range$1.30 - $1.44
    5 analysts
    EPS Revisions
    1
    0
    7d
    2
    1
    30d
    EPS Estimate Drift
    90d ago$1.29-5.0%
    60d ago$1.30-4.2%
    30d ago$1.29-4.7%
    7d ago$1.38+2.2%
    Current$1.35
    Revenue Consensus
    $361M
    Range$354M - $368M
    7 analysts
    Dec 31, 2026
    EPS Consensus$1.71
    Range$1.56 - $1.80
    3 analysts
    Revenue Consensus
    $421M
    Range$403M - $439M
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$1.71---
    Sep 26EST
    		-$1.35---
    Jun 26
    		$1.32$1.11+18.92%Beat-15.9%
    Mar 26
    		$1.46$1.23+18.70%Beat-4.6%
    Dec 25
    		$1.46$0.94+55.32%Beat-8.2%
    Sep 25
    		$1.27$1.27+0.00%Beat-25.3%
    Jun 25
    		$1.57$1.68-6.55%Miss-12.8%
    Mar 25
    		$1.53$1.65-7.27%Miss-9.5%
    Dec 24
    		$1.59$1.54+3.04%Beat-9.1%
    Sep 24
    		$1.70$1.56+8.97%Beat+15.6%
    Jun 24
    		$1.80$1.83-1.64%Miss+16.9%
    Mar 24
    		$1.69$1.54+9.74%Beat+15.0%
    Dec 23
    		$1.75$1.45+20.69%Beat+27.7%
    Sep 23
    		$1.47$1.32+11.36%Beat+48.5%
    Jun 23
    		$1.54$1.31+17.56%Beat+73.0%
    Mar 23
    		$1.47$1.29+13.95%Beat+51.5%
    Dec 22
    		$1.37$0.96+42.71%Beat+448.0%
    Sep 22
    		$0.99$0.83+19.28%Beat+1137.5%
    Jun 22
    		$0.89$0.70+27.14%Beat+709.1%
    Mar 22
    		$0.97$0.46+110.87%Beat+1840.0%
    Dec 21
    		$0.25$0.17+47.06%Beat+257.1%
    Sep 21
    		$0.08$0.06+33.33%Beat+100.0%
    Jun 21
    		$0.11$0.05+120.00%Beat+10.0%
    Mar 21
    		$0.05$-0.01+600.00%Beat-86.1%
    Dec 20
    		$0.07$0.01+600.00%Beat-79.4%
    Sep 20
    		$0.04$-0.06+166.67%Beat-85.7%
    Jun 20
    		$0.10$0.06+66.67%Beat-63.0%
    Mar 20
    		$0.36$0.29+24.14%Beat+28.6%
    Dec 19
    		$0.34$0.30+13.33%Beat+41.7%
    Sep 19
    		$0.28$0.21+33.33%Beat+16.7%
    Jun 19
    		$0.27$0.25+8.00%Beat+3.8%
    Mar 19
    		$0.28$0.25+12.00%Beat+27.3%
    Dec 18
    		$0.24$0.14+71.43%Beat+100.0%
    Sep 18
    		$0.24$0.18+33.33%Beat+0.0%
    Jun 18
    		$0.26$0.22+18.18%Beat-38.1%
    Mar 18
    		$0.22$0.22+0.00%Beat-21.4%
    Dec 17
    		$0.12$0.20-40.00%Miss-33.3%
    Sep 17
    		$0.24$0.20+20.00%Beat+60.0%
    Jun 17
    		$0.42$0.23+82.61%Beat-
    Mar 17
    		$0.28$0.19+47.37%Beat-
    Dec 16
    		$0.18$0.13+38.46%Beat-
    Sep 16
    		$0.15$0.07+114.29%Beat-

    Key Metrics

    Valuation
    P/E Ratio18.32EV/EBITDA13.98x
    Price/FCF13.37xFCF Yield7.48%
    Profitability
    Profit Margin17.70%Operating Margin25.80%
    ROE22.20%ROIC15.42%
    Financial Health
    Debt/Equity0.44xInterest Coverage19.33x
    Current Ratio3.06xQuick Ratio2.89x
    Trading Statistics
    Beta-0.03Avg Volume2.09M
    52-Week High$111.8652-Week Low$49.67

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$100.56
    SMA 20$100.77
    SMA 50$103.56
    SMA 200$83.26
    EMA 10$100.74
    EMA 20$101.10
    EMA 50$101.05
    EMA 200$88.90

    MACD

    Line: -0.56Signal: -0.71Hist: 0.15

    ADX

    ADX: 11.7+DI: 19.5-DI: 22.8

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down16.0
    PSAR$101.45

    Bollinger Bands

    Upper Band$101.47
    Lower Band$100.08
    %B Position138%(Upper)
    Band Width0.63

    RSI (14-Day)

    Neutral
    47.6

    Momentum Oscillators

    Stoch %K56.1
    Stoch %D52.1
    Williams %R-27.2
    ROC (10d)0.0%
    Momentum0.05
    CCI (20d)20.7
    MFI (14d)38.3

    Volatility Measures

    ATR (14d)$1.28(1.3%)
    StdDev (20d)0.35
    Hist Vol5.2%(Low)

    Volume Flow

    VWAP$100.87
    OBV2.1M
    AD Line32.5M
    CMF (20d)-0.199

    Volume Metrics

    Avg Vol (20d)1.8M
    Vol Ratio0.5x(Low)
    VWMA (20d)$100.79

    Pivot Points

    R3$101.53
    R2$101.22
    R1$101.00
    Pivot Point$100.69
    S1$100.46
    S2$100.15
    S3$99.92

    Advanced Oscillators

    TSI-9.22
    Ultimate Osc48.2
    KST-29.86

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$388.18M$377.33M$406.79M$384.01M$378.05M$372.76M$391.11M$378.73M$394.09M$369.98M$354.00M$319.95M
    Cost of Revenue$146.32M$146.41M$165.91M$161.65M$137.03M$135.06M$142.56M$136.61M$138.32M$118.20M$124.13M$120.00M
    Gross Profit$241.85M$230.92M$240.88M$222.37M$241.01M$237.70M$248.54M$242.13M$255.77M$251.78M$229.87M$199.95M
    Operating Expenses$141.64M$149.60M$163.69M$178.75M$153.04M$135.63M$134.67M$108.38M$153.04M$151.40M$92.38M$87.59M
    R&D$38.20M$39.38M$47.48M$48.02M$45.49M$36.31M$35.33M$24.15M$60.60M$48.02M$16.82M$14.45M
    SG&A$20.63M$57.53M$69.89M$81.90M$66.52M$56.82M$57.87M$40.52M$47.41M$47.90M$40.30M$35.74M
    Operating Income$100.22M$81.33M$77.18M$43.62M$87.97M$102.07M$113.87M$133.74M$102.73M$100.38M$137.49M$112.36M
    Interest Income$6.26M$4.97M$3.07M$3.62M$7.21M$9.48M$9.56M$9.80M$8.92M$8.55M$7.55M$4.54M
    Interest Expense$4.92M$4.86M$5.08M$4.95M$4.92M$4.80M$5.04M$4.90M$4.86M$4.86M$5.04M$5.05M
    Income Before Tax$93.83M$156.41M$70.36M$42.38M$104.52M$96.53M$-783,000$176.12M$84.37M$171.27M$138.40M$159.96M
    Income Tax Expense$18.80M$37.99M$16.28M$14.61M$25.76M$23.58M$11.01M$45.02M$22.30M$40.20M$35.02M$28.00M
    Net Income$75.03M$118.42M$54.09M$27.77M$78.75M$72.94M$-11,790,000$131.09M$62.07M$131.07M$103.38M$131.96M
    EBITDA$115.44M$183.95M$98.26M$67.74M$122.67M$114.96M$21.55M$198.10M$104.06M$191.57M$158.46M$179.66M
    EBIT$98.74M$161.27M$75.44M$47.33M$109.43M$101.33M$4.26M$181.02M$89.24M$176.13M$143.44M$165.01M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about LNTH

    Government Contracts

    Gov Obligations (TTM)
    $41.10M
    Gov Obligations / Revenue
    2.7%
    Obligations YoY
    39.5%
    Active Awards
    84
    New Awards (TTM)
    39
    Avg Remaining Term
    4.9 mo

    Top agency: Department of Veterans Affairs at 96.1% of trailing twelve month obligations across 3 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C25026N0354Department of Veterans AffairsDepartment of Veterans Affairs$2.36MMar 1, 2026
    36C25026N0359Department of Veterans AffairsDepartment of Veterans Affairs$1.97MMar 1, 2026
    36C25726N0177Department of Veterans AffairsDepartment of Veterans Affairs$1.81MJan 6, 2026
    36C24526N0180Department of Veterans AffairsDepartment of Veterans Affairs$1.81MJan 2, 2026
    36C26126N0023Department of Veterans AffairsDepartment of Veterans Affairs$1.73MOct 1, 2025
    36C26226F0031Department of Veterans AffairsDepartment of Veterans Affairs$1.57MNov 4, 2025
    36C24626N0284Department of Veterans AffairsDepartment of Veterans Affairs$1.50MJan 1, 2025
    36C24826N0189Department of Veterans AffairsDepartment of Veterans Affairs$1.25MJan 1, 2026
    36C24625N1142Department of Veterans AffairsDepartment of Veterans Affairs$1.21MSep 1, 2025
    36C24826N0071Department of Veterans AffairsDepartment of Veterans Affairs$1.20MOct 1, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Healthcare Equipment and Supplies Stocks Q2 Recap: Benchmarking Lantheus (NASDAQ:LNTH)

    The article provides a Q2 recap for the healthcare equipment and supplies sector, focusing on Lantheus (NASDAQ:LNTH) and its peers. It highlights the sector's strong performance, driven by innovation, an aging population, and advancements in technology, despite challenges like pricing pressure and supply chain disruptions. The report details the financial results of Lantheus, Baxter, LeMaitre, Teleflex, and Inspire Medical Systems, assessing their revenue growth and EPS performance against analyst expectations.

    Yahoo Finance•8/21/26•
    Neutral

    Lantheus Holdings CAO Kimberly Brown Sells 463 Shares for Tax Withholding Purposes

    Kimberly Brown, Chief Accounting Officer of Lantheus Holdings (NASDAQ:LNTH), sold 463 shares of common stock on August 17, 2026. This transaction, conducted at $100.91 per share, was for tax withholding purposes related to equity awards. Following the sale, Brown's direct ownership in the company stands at 13,263 common stock shares.

    Kalkine Media•8/19/26•
    Neutral

    Lantheus Holdings, Inc. Stock 12‑Month Price Target Cut to $106.3, Implies 6% Upside

    Lantheus Holdings, Inc.'s average 12-month price target has been adjusted to $106.3 by 8 analysts, a slight decrease from $107.16. This new target suggests a potential upside of approximately 6% from its August 18 closing price. The consensus rating for LNTH remains "Hold" among 11 analysts.

    TradingView•8/19/26•
    Somewhat-Bearish

    B.Riley downgrades Lantheus stock rating on Curium acquisition

    B.Riley downgraded Lantheus Holdings (NASDAQ:LNTH) to Neutral from Buy and reduced its price target following Curium's agreement to acquire Lantheus. The acquisition is set at $102.50 per share plus potential contingent value rights, with the transaction expected to close in the first half of 2027. Despite the downgrade, InvestingPro data indicates Lantheus stock may still be undervalued.

    Investing.com•8/18/26•
    Somewhat-Bearish

    Lantheus Holdings’ Alzheimer’s radiodiagnostic secures FDA approval

    Lantheus Holdings has received FDA approval for its radiodiagnostic agent, Tauklarify, for identifying tau pathology in adults being evaluated for Alzheimer's disease. Tauklarify is used for PET imaging of the brain to identify tau neurofibrillary tangle (NFT) pathology, a key biomarker for Alzheimer's. The approval was based on two blinded read studies demonstrating high accuracy and inter-reader agreement.

    Yahoo•8/17/26•
    Bullish

    Frequently Asked Questions About LNTH

    Does LNTH pay dividends?
    Lantheus Holdings Inc (LNTH) does not currently pay a regular dividend.
    What is LNTH's P/E ratio?
    Lantheus Holdings Inc has a price-to-earnings (P/E) ratio of 18.32.
    What is LNTH's market cap?
    Lantheus Holdings Inc (LNTH) has a market capitalization of $6.58B with a current stock price of $100.96.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In